Erratum: 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells (Oncol Rep (2016) 36 (1157-1165) DOI: 10.3892/or.2016.4848);7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells

Oncology Reports

Volumn 36, Issue 2, 2016, Pages 1157-1165

  Cao, Xiaozheng ^a,b   Ren, Kaiqun ^a   Song, Zhengwei ^a   Li, Duo ^a   Quan, Meifang ^a   Zheng, Yu ^a   Cao, Jianguo ^a   Zeng, Wenbin ^b   Zou, Hui ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

4' di n octyl genistein; 7 difluoromhoxyl 5; Cancer stem like cells; Epithelial mesenchymal transition; FoxM1; Gastric cancer; Gastric cancer stem like cells; Twist

Indexed keywords

7 DIFLUOROMETHOXYL 5,4' DI N OCTYL GENISTEIN; CARRIER PROTEINS AND BINDING PROTEINS; CD133 ANTIGEN; FORKHEAD BOX M1 PROTEIN; GENISTEIN; HERMES ANTIGEN; NERVE CELL ADHESION MOLECULE; PROTEIN ALDH1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; TWIST 1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; 7-DIFLUOROMETHOXYL-5,4'-DI-N-OCTYLGENISTEIN; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CADHERIN; CD44 PROTEIN, HUMAN; FORKHEAD BOX PROTEIN M1; ISOENZYME; RETINAL DEHYDROGENASE; TWIST RELATED PROTEIN 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL SELF-RENEWAL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; GASTRIC CANCER CELL LINE; GASTRIC CANCER STEM LIKE CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; METABOLISM; PATHOLOGY; PROCEDURES; STOMACH NEOPLASMS; TUMOR CELL LINE; TUMOR INVASION;

AC133 ANTIGEN; ANTIGENS, CD44; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FORKHEAD BOX PROTEIN M1; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; ISOENZYMES; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PHENOTYPE; RETINAL DEHYDROGENASE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION; TWIST-RELATED PROTEIN 1;

EID: 84976520263     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/OR.2022.8391     Document Type: Erratum

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
3. Bonnet D and Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737, 1997.
4. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD and Steindler DA: Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39: 193-206, 2002.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
6. Yu SC, Ping YF, Yi L, Zhou ZH, Chen JH, Yao XH, Gao L, Wang JM and Bian XW: Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett 265: 124-134, 2008.
7. Kim Y, Wu Q, Hamerlik P, Hitomi M, Sloan AE, Barnett GH, Weil RJ, Leahy P, Hjelmeland AB and Rich JN: Aptamer identification of brain tumor-initiating cells. Cancer Res 73: 4923-4936, 2013.
8. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 67: 1030-1037, 2007.
9. Chen K, Huang YH and Chen JL: Understanding and targeting cancer stem cells: Therapeutic implications and challenges. Acta Pharmacol Sin 34: 732-740, 2013.
10. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC: Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020, 2009.
11. Jiang J, Zhang Y, Chuai S, Wang Z, Zheng D, Xu F, Zhang Y, Li C, Liang Y and Chen Z: Trastuzumab Herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Oncogene 31: 671-682, 2012.
12. Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y and Wu C: Antagonism of miR-21 reverses epithelialmesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 7: e39520, 2012.
13. Li K, Dan Z and Nie YQ: Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. World J Gastroenterol 20: 5420-5426, 2014.
14. Liu J, Ma L, Xu J, Liu C, Zhang J, Liu J, Chen R and Zhou Y: Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. Int J Oncol 42: 453-459, 2013.
15. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, et al: The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 66: 2153-2161, 2006.
16. Zeng J, Wang L, Li Q, Li W, Björkholm M, Jia J and Xu D: FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kip1. J Pathol 218: 419-427, 2009.
17. Wang Z, Banerjee S, Kong D, Li Y and Sarkar FH: Downregulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300, 2007.
18. Laoukili J, Stahl M and Medema RH: FoxM1: At the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102, 2007.
19. Wang IC, Ustiyan V, Zhang Y, Cai Y, Kalin TV and Kalinichenko VV : Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic KrasG12D. Oncogene 33: 5391-5396, 2014.
20. Yu G, Zhou A, Xue J, Huang C, Zhang X, Kang SH, Chiu WT, Tan C, Xie K, Wang J, et al: FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway. Oncotarget 6: 11281-11294, 2015.
21. Miao L, Xiong X, Lin Y, Cheng Y, Lu J, Zhang J and Cheng N: Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells. Cancer Genet 207: 75-82, 2014.
22. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, Li Y, Azmi AS, Miele L and Sarkar FH: Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 112: 2296-2306, 2011.
23. Ning YX, Li QX, Ren KQ, Quan MF and Cao JG: 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1. Oncol Lett 8: 295-300, 2014.
24. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927-939, 2004.
25. Khan MA, Chen HC, Zhang D and Fu J: Twist: A molecular target in cancer therapeutics. Tumour Biol 34: 2497-2506, 2013.
26. Bourgeois P, Stoetzel C, Bolcato-Bellemin AL, Mattei MG and Perrin-Schmitt F: The human H-twist gene is located at 7p21 and encodes a B-HLH protein that is 96% similar to its murine M-twist counterpart. Mamm Genome 7: 915-917, 1996.
27. V esuna F, Lisok A, Kimble B and Raman V: Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318-1328, 2009.
28. Li J and Zhou BP: Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11: 49, 2011.
29. Xiang HL, Liu F, Quan MF, Cao JG and Lv Y: 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1. World J Gastroenterol 18: 4618-4626, 2012.
30. Ning Y, Luo C, Ren K, Quan M and Cao J: FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein. Mol Med Rep 9: 1982-1988, 2014.
31. Cao JG, Cao XZ and Xiang HL: Patent CN 201210591131.2. Filed December 22, 2012.
32. Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY and Liu C: FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World J Gastroenterol 21: 196-213, 2015.
33. Ren KQ, Cao XZ, Liu ZH, Guo H, Quan MF, Liu F, Jiang L, Xiang HL, Deng XY and Cao JG: 8-Bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling. Int J Oncol 43: 1719-1729, 2013.
34. He M, Cao XC, He GC, Sheng XF, Ai XH and Wu YH: Casticin inhibits epithelial-mesenchymal transition of liver cancer stem cells of the SMMC-7721 cell line through downregulating Twist. Oncol Lett 7: 1625-1631, 2014.
35. Qian J, Luo Y, Gu X, Zhan W and Wang X: Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1. PLoS One 8: e77625, 2013.